Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan

World Journal of Gastroenterology

Volumn 11, Issue 25, 2005, Pages 3905-3908

  Lin, Tsung Jung ^a   Lin, Chih Lin ^a   Wang, Chaur Shine ^a   Liu, Shu O ^a   Liao, Li Ying ^a  

^a JEN AI HOSPITAL   (Taiwan)

Author keywords

Chronic hepatitis C; Hereditary hemochromatosis; HFE gene; Nonalcoholic fatty liver disease; Serum iron

Indexed keywords

ASPARTIC ACID; BIOLOGICAL MARKER; CYSTEINE; FERRITIN; HFE PROTEIN; HISTIDINE; IRON; TYROSINE;

ADULT; AGED; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; FEMALE; GENE MUTATION; HEPATITIS C; HETEROZYGOSITY; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON OVERLOAD; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PREVALENCE; STATISTICAL SIGNIFICANCE; TAIWAN;

EID: 22644438762     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i25.3905     Document Type: Article

References (27)

1. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatatosis mutations. J Med Genet 1997; 34: 275-278
2. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donars. N Engl J Med 1988; 318: 1355-1362
3. Powell LW, Halliday JW, Cowlishaw JL. Relationship between serum ferritin and total body iron stores in idiopathic haemochromatosis. Gut 1978; 19: 538
4. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996; 110: 1107-1119
5. Feder JN, Ginirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK. A novel MHC class-like gene is mutated in patients with hereditary haematochromatosis. Nat Genet 1996; 13: 399-408
6. Jazwinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW, Morris CP, Walsh TP. Haematochromatosis and HLA-H. Nat Genet 1996; 14: 249
7. Jouanolle AM, Gandon G, Jezequel P, Blayau M, Campion ML, Yaouanq J, Mosser J, Fergelot P, Chauvel B, Bouric P, Carn G, Andrieux N, Gicquel I, Le Gall JY, David V. Haematochromatosis and HLA-H. Nat Genet 1996; 14: 251
8. Consortium UH. A simple genetic test identifies 90% of UK patients with hemochromatosis. Gut 1997; 41: 841-844
9. Datz C, Lalloz MR, Vogel W, Graziadei I, Hackl F, Vautier G, Layton DM, Maier-Dobersberger TH, Ferenci P, Penner E, Sandhofer F, Bomford A, Paulweber B. Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic hemochromatosis. J Hepatol 1997; 27: 773-779
10. Piperno A, Sampietro M, Pietrangelo A, Arosio C, Lupica L, Montosi G, Vergani A, Fraquelli M, Girelli D, Pasquero P, Roetto A, Gasparini P, Fargion S, Conte D, Camaschella C. Heterogeneity of hemochromatosis in Italy. Gastroenterology 1998; 114: 996-1002
11. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999; 341: 718-724
12. Chang JG, Liu TC, Lin SF. Rapid diagnosis of the HLA-H gene Cys 282 Tyr mutation in haemochromatosis by polymerase chain reaction-A very rare mutation in the Chinese population. Blood 1997; 89: 3492
13. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 1996; 335: 1799-1805
14. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992; 102: 2108-2113
15. Riggio O, Montagnese F, Fiore P, Folino S, Giambartolomei S, Gandin C, Merli M, Quinti I, Violante N, Caroli S, Senofonte O, Capocaccia L. Iron overload in patients with chronic viral hepatitis: how common is it? Am J Gastroenterol 1997; 92: 1298-1301
16. Piperno A, D'Alba R, Fargion S, Roffi L, Sampietro M, Parma S, Arosio V, Fare M, Fiorelli G. Liver iron concentration in chronic viral hepatitis: a study of 98 patients. Eur J Gastroenterol Hepatol 1995; 7: 1203-1208
17. Bonkovsky HL, Banner BE, Lambrecht RW, Rubin RB. Iron in liver diseases other than hemochromatosis. Semin Liver Dis 1996; 16: 65-82
18. George DK, Goldwurm S, MacDonald GA, Cowley LL, Walker NI, Ward PJ, Jazwinska EC, Powell LW. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998; 114: 311-318
19. Bacon BR, Britton RS. The pathology of hepatic iron overload: a free radical-mediated process? Hepatology 1990; 11: 127-137
20. Bonkovsky HL, Banner BF, Rothman AL. Iron and chronic viral hepatitis. Hepatology 1997; 25: 759-768
21. Caroline L. A cheaper and more rapid polymerase chain reaction-restriction fragment length polymorphism method for the detection of the HLA-H gene mutations occurring in hereditary hemochromatosis. Blood 1007; 90: 4235
22. Shiono Y, Ikeda R, Hayashi H, Wakusawa S, Sanae F, Takikawa T, Imaizumi Y, Yano M, Yoshioka K, Kawanaka M, Yamada G. C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan. Internal Medicine 2001; 40: 852-856
23. Smith BC, Grove J, Guzail MA, Day CP, Daly AK, Burt AD, Bassendine MF. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 1998; 27: 1695-1699
24. Kazemi-Shirazi L, Datz C, Maier-Dobersberger T, Kaserer K, Hackl F, Polli C, Steindl PE, Penner E, Ferenci P. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology 1999; 116: 127-134
25. Erhardt A, Maschner-Olberg A, Mellenthin C, Kappert G, Adams O, Donner A, Willers R, Niederau C, Haussinger D. HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis. J Hepatol 2003; 3: 335-342
26. Chitturi S, Weltman M, Farrell GC, McDonald D, Liddle C, Samarasinghe D, Lin R, Abeygunasekera S, George J. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity. Hepatology 2002; 36: 142-149
27. Bonkovsky HL, Jawaid Q, Tortorelli K, LeClair P, Cobb J, Lambrecht RW, Banner BF. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in the non-alcoholic steatohepatitis. J Hepatol 1999; 31: 421-429